Product ID:CYTOSAR-U STERILE POWDER
MSDS Date:01/01/1987
FSC:6505
NIIN:00D003336
MSDS Number: BTWTT

Emergency Phone: 616-323-6722 (24 HOURS)

Info Phone: 30 PM)

Cage: 93703

Telephone: 616-833-5122/616-833-7555

Cage: 93703

CYTARABINE OR CYTOSINE B-D-ARABINOFURANOSIDE

CAS: 147-94-4

RTECS: HA5425000

Fraction By Weight: <100%

LD50 LC50 Mixture:ORAL LD50 (RAT) IS >3000 MG/KG
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:REPEATED OR CONTINUOUS SKIN/EYE
CONTACT MAY CAUSE IRRITATION.INTERVENOUS INFUSION MAY CAUSE GI
TRACT DISTURBANCES & ANOREXIA;BONE MARROW SUPPRESSION & LOSS OF
IMMUNE RESPONSE.CHRONIC:CYTARABINE IS KNO WN TO BE
TERATOGENIC.PRIMARY CHRONIC EFFECT IS BONE MARROW SUPPRESSION &
IMMUNOSUPPRESSION.CNS DAMAGE HAS BEEN REPORTED.
Explanation of Carcinogenicity:NO INGREDIENT OF A CONCENTRATION OF 0.1%
OR GREATER IS LISTED AS A CARCINOGEN OR SUSPECTED CARCINOGEN.
Effects of Overexposure:INFUSION-NAUSEA, VOMITING, DIARRHEA. EYES:
REDNESS, TEARING, DISCOMFORT. SKIN: REDNESS, DISCOMFORT.
Medical Cond Aggravated by Exposure:HYPERSENSITIVITY TO CYTARABINE.

First Aid:EYES-FLUSH WITH LOTS OF WATER FOR 15 MINUTES, HOLD LIDS OPEN.
SKIN-REMOVE CONTAMINATED CLOTHES. WASH WITH SOAP AND WATER.
INHALED-REMOVE TO FRESH AIR. INGESTED-CONTACT A PHYSICIAN OR POISON
CONTROL CE NTER.

Flash Point:NONFLAMMABLE
Extinguishing Media:WATER, ALCOHOL FOAM, CARBON DIOXIDE OR DRY
CHEMICAL.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
FULL-BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:FINELY DIVIDED ORAGNIC POWDER; MAY BE
EXPLOSION HAZARD UNDER CERTAIN DUSTY CONDITION. CONTROL DUST
LEVELS, ELIMINATE STATIC ELECTRICITY BUILD-UP/DISCHARGE.

Spill Release Procedures:REMOVE IGNITION SOURCES.PROVIDE VENTILATION &
RESPIRATORY,SKIN & EYE PRTECTION.KEEP PRODUCT OUT OF DRAINS;PREVENT
ENTRY INTO GROUNDWATER,SURFACE WATER & SOIL.ABSORB SMALL SPILLS
WITH PAPER TOWEL OR SI MILAR MATERIAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:STORE IN A COOL, DRY PLACE AND PROTECT
FROM LIGHT. KEEP OUT OF REACH OF CHILDREN. AVOID CONTACT WITH SKIN,
EYES OR CLOTHING.
Other Precautions:WASH THOROUGHLY AFTER HANDLING. LAUNDER CONTAMINATED
CLOTHES BEFORE REUSE.

Respiratory Protection:NONE NORMALLY REQUIRED.
Ventilation:LOCAL EXHAUST.
Protective Gloves:NONE NORMALLY REQUIRED.
Eye Protection:NONE NORMALLY REQUIRED.
Other Protective Equipment:NONE NORMALLY REQUIRED.
Work Hygienic Practices:WASH HANDS THOROUGHLY AFTER USE. LAUNDER
CONTAMINATED CLOTHES BEFORE REUSE.
Supplemental Safety and Health
MSDS APPLIES TO FOLLOWING NDC NUMBERS: 0009-0373-01; 0009-0473-01;
0009-3295-01; 0009-3296-01. HUMAN DRUG USED IN THE TREATMENT OF
VARIOUS LEUKEMIAS OF ADULTS AND CHILDREN.

HCC:K2
Appearance and Odor:WHITE TO OFF-WHITE CRYSTALLINE POWDER PACKAGED IN
100 MG,500 MG,1G & 2G QUANTIT

Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:CARBON MONOXIDE AND CARBON DIOXIDE;
NITROGEN OXIDES.

Waste Disposal Methods:DISPOSE OF BY INCINERATION IN ACCORDANCE WITH
APPLICABLE INTERNATIONAL, LOCAL, STATE AND FEDERAL WASTE DISPOSAL
REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.